Hematopoietic Cell Growth Factors
"Hematopoietic Cell Growth Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
These growth factors comprise a family of hematopoietic regulators with biological specificities defined by their ability to support proliferation and differentiation of blood cells of different lineages. ERYTHROPOIETIN and the COLONY-STIMULATING FACTORS belong to this family. Some of these factors have been studied and used in the treatment of chemotherapy-induced neutropenia, myelodysplastic syndromes, and bone marrow failure syndromes.
| Descriptor ID |
D016298
|
| MeSH Number(s) |
D12.644.276.374.410 D12.776.467.374.410 D23.529.374.410
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hematopoietic Cell Growth Factors".
Below are MeSH descriptors whose meaning is more specific than "Hematopoietic Cell Growth Factors".
This graph shows the total number of publications written about "Hematopoietic Cell Growth Factors" by people in this website by year, and whether "Hematopoietic Cell Growth Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hematopoietic Cell Growth Factors" by people in Profiles.
-
Dnmt3a-null hematopoietic stem and progenitor cells expand after busulfan treatment. Exp Hematol. 2020 11; 91:39-45.e2.
-
Increased blood myeloid dendritic cells and dendritic cell-poietins in Langerhans cell histiocytosis. J Immunol. 2005 Mar 01; 174(5):3067-71.
-
Future directions with hematopoietic growth factors. J Natl Compr Canc Netw. 2003 Jan; 1 Suppl 1:S96-101.
-
Biologic response modifiers in pediatric cancer. Hematol Oncol Clin North Am. 2001 Aug; 15(4):723-40, ix.
-
Clinical applications of filgrastim and stem cell factor in vivo and in vitro. J Hematother. 1994; 3(4):353-5.
-
Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro. Exp Hematol. 1993 Apr; 21(4):545-51.
-
Hematopoietic growth factor therapy of myelodysplastic syndromes. Leuk Lymphoma. 1993; 11 Suppl 2:65-9.
-
Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci U S A. 1992 May 01; 89(9):4109-13.
-
The kit receptor and its ligand, steel factor, as regulators of hemopoiesis. Cancer Cells. 1991 Dec; 3(12):480-7.
-
Dose intensity as a therapeutic strategy in breast cancer. Breast Cancer Res Treat. 1991 Dec; 20 Suppl:S11-4.